Entrada Therapeutics: Executives
Dipal DoshiChief Executive OfficerFY2025
Nathan J. DowdenPresident and Chief Operating OfficerFY2024
Natarajan Sethuraman Ph. D.President of Research and DevelopmentFY2025
3 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.